Welcome to our dedicated page for Endexx news (Ticker: EDXC), a resource for investors and traders seeking the latest updates and insights on Endexx stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Endexx's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Endexx's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Endexx Corporation (OTC:EDXC) announced a significant distribution agreement to sell its HYLA products in Egypt, valued over $1,000,000 USD for the next year, starting with a $200,000 USD initial order. The Egyptian market is experiencing a 15% annual growth in vape products, reflecting a growing demand for non-nicotine alternatives, as 24% of the population uses tobacco. CEO Todd Davis highlighted the brand’s successful expansion into international markets. The agreement aligns with the company’s mission of providing sustainable health and skincare solutions.
FAQ
What is the current stock price of Endexx (EDXC)?
What is the market cap of Endexx (EDXC)?
